Observed in breast cancer treatment, Herceptin, which is also associated with chemotherapy, improves the lifespan of different stages of breast cancer.70 Haggett and colleagues have developed a CAR bispecific molecule targeting HER2 and IL-13Rα2 antigens in cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.